Skip to content

LSD: all studies

Page 47 of 282: studies 461 to 470 of 2,815, newest first. Back to the LSD overview

Research

Chronic LSD alters gene expression profiles in the mPFC relevant to schizophrenia

Neuropharmacology April 3, 2014 David Martin, Danuta Marona‐lewicka, D. E. Nichols et al.

Chronic administration of lysergic acid diethylamide (LSD) every other day to rats results in a variety of abnormal behaviors. These build over the 90 day course of treatment and can persist at full strength for at least several months after cessation of treatment. The behaviors are consistent with those observed in animal models of schizophrenia and include hyperactivity, reduced...

Safety and Efficacy of Lysergic Acid Diethylamide-Assisted Psychotherapy for Anxiety Associated With Life-threatening Diseases

The Journal of Nervous and Mental Disease March 4, 2014 Peter Gasser, Dominique Holstein, Yvonne Michel et al. 752 citations

A double-blind, randomized, active placebo-controlled pilot study was conducted to examine safety and efficacy of lysergic acid diethylamide (LSD)-assisted psychotherapy in 12 patients with anxiety associated with life-threatening diseases. Treatment included drug-free psychotherapy sessions supplemented by two LSD-assisted psychotherapy sessions 2 to 3 weeks apart. The participants received...

Self-Experimentations with Psychedelics Among Mental Health Professionals: LSD in the Former Czechoslovakia

Journal of Psychoactive Drugs 2014 Petr Winkler, Ladislav Csémy 36 citations

This article enquires into auto-experiments with psychedelics. It is focused on the experiences and current attitudes of mental health professionals who experimented with LSD in the era of legal research of this substance in the former Czechoslovakia. The objective of the follow-up study presented was to assess respondents' long-term views on their LSD experience(s). A secondary objective was...

DOI: 10.1080/02791072.2013.873158 (opens in new tab) Mental health Clinical psychology

Psychedelics as medicines for substance abuse rehabilitation: evaluating treatments with LSD, Peyote, Ibogaine and Ayahuasca.

Current Drug Abuse Reviews 2014 Michael Winkelman 128 citations

Substances known as psychedelics, hallucinogens and entheogens have been employed in ethnomedical traditions for thousands of years, but after promising uses in the 1950's and 1960's they were largely prohibited in medical treatment and human research starting in the 1970's as part of the fallout from the war on drugs. Nonetheless, there are a number of studies which suggest that these...

DOI: 10.2174/1874473708666150107120011 (opens in new tab) Full text (opens in new tab) Psychedelic addiction treatment Psychedelic therapeutic mechanisms Psychedelic drug safety

Edited by Allan Beveridge, Femi Oyebode and Rosalind Ramsay - LSD: My Problem Child By Albert Hofmann (transl. Jonathan Ott) Oxford University Press. 2013. £24.99 (hb). 248 pp. ISBN: 9780199639410

The British Journal of Psychiatry August 1, 2013 Ben Sessa

Edited by Allan Beveridge, Femi Oyebode and Rosalind Ramsay - LSD: My Problem Child By Albert Hofmann (transl. Jonathan Ott) Oxford University Press. 2013. £24.99 (hb). 248 pp. ISBN: 9780199639410 - Volume 203 Issue 2

The HIV antiretroviral drug efavirenz has LSD-like properties.

Neuropsychopharmacology May 24, 2013 Michael B. Gatch, Alexey Kozlenkov, Ren-Qi Huang et al.

Anecdotal reports have surfaced concerning misuse of the HIV antiretroviral medication efavirenz ((4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-2,4-dihydro-1H-3,1-benzoxazin-2-one) by HIV patients and non-infected teens who crush the pills and smoke the powder for its psychoactive effects. Molecular profiling of the receptor pharmacology of efavirenz pinpointed interactions with...

Argyreia nervosa (Burm. f.): Receptor profiling of lysergic acid amide and other potential psychedelic LSD-like compounds by computational and binding assay approaches

Journal of Ethnopharmacology May 8, 2013 Alexander Paulke, Christian Kremer, Cora Wunder et al. 31 citations

Ethnopharmacological relevanceThe convolvulacea Argyreia nervosa (Burm. f.) is well known as an important medical plant in the traditional Ayurvedic system of medicine and it is used in numerous diseases (e.g. nervousness, bronchitis, tuberculosis, arthritis, and diabetes). Additionally, in the Indian state of Assam and in other regions Argyreia nervosa is part of the traditional tribal...

DOI: 10.1016/j.jep.2013.04.044 (opens in new tab) Traditional medicine Context archaeology Pharmacology

[The substance experience, a history of LSD].

Medecine sciences : M/S April 1, 2013 François Beck, Nicolas Bonnet 6 citations

This article reviews the recent knowledge on LSD stemming from various disciplines among which pharmacology, sociology and epidemiology. The d-lysergic acid diethylamide (LSD) is a particularly powerful hallucinogenic substance. It produces distortions and hearing, visual and tactile hallucinations. Rarely used (only 1.7% of people aged 15-64 years old have tried it in their lifetime), this...

Chronic treatment with LY341495 decreases 5-HT2A receptor binding and hallucinogenic effects of LSD in mice

Neuroscience Letters January 16, 2013 José L. Moreno, Terrell Holloway, Vinayak Rayannavar et al. 44 citations

Hallucinogenic drugs, such as lysergic acid diethylamide (LSD), mescaline and psilocybin, alter perception and cognitive processes. All hallucinogenic drugs have in common a high affinity for the serotonin 5-HT(2A) receptor. Metabotropic glutamate 2/3 (mGlu2/3) receptor ligands show efficacy in modulating the cellular and behavioral responses induced by hallucinogenic drugs. Here, we explored...

LSD-unterstützte Psychotherapie : Heilung durch veränderte Bewusstseinszustände

Zürcher Hochschule für Angewandte Wissenschaften digital collection 2013 Susanne Hürlimann

Diese empirische Arbeit geht der Frage nach, worin der Nutzen der LSD-u PT liegt und wie sie aufgrund dessen das Therapieangebot bereichern könnte.Dies wurde mit qualitativen Interviews untersucht.Bei den Interviewten handelt es sich um vier Schweizer Psychiater, die alle über eine Ausbildung in dieser Therapiemethode sowie über jahrelange Therapieerfahrung verfügen.Aus den Ergebnissen der...